Abstract:Background: DNA Methylation is one of the most important epigenetic processes that are crucial to regulating the functioning of the human genome without altering the DNA sequence. DNA Methylation data for cancer patients are becoming more accessible than ever, which is attributed to newer DNA sequencing technologies, notably, the relatively low-cost DNA microarray technology by Illumina Infinium. This technology makes it possible to study DNA methylation at hundreds of thousands of different loci. Currently, most of the research found in the literature focuses on the discovery of DNA methylation markers for specific cancer types. A relatively small number of studies have attempted to find unified DNA methylation biomarkers that can diagnose different types of cancer (pan-cancer classification). Results: In this study, the aim is to conduct a pan-classification of cancer disease. We retrieved individual data for different types of cancer patients from The Cancer Genome Atlas (TCGA) portal. We selected data for many cancer types: Breast Cancer (BRCA), Ovary Cancer (OV), Stomach Cancer (STOMACH), Colon Cancer (COAD), Kidney Cancer (KIRC), Liver Cancer (LIHC), Lung Cancer (LUSC), Prostate Cancer (PRAD) and Thyroid cancer (THCA). The data was pre-processed and later used to build the required dataset. The system that we developed consists of two main stages. The purpose of the first stage is to perform feature selection and, therefore, decrease the dimensionality of the DNA methylation loci (features). This is accomplished using an unsupervised metaheuristic technique. As for the second stage, we used supervised machine learning and developed deep neural network (DNN) models to help classify the samples' malignancy status and cancer type. Experimental results showed that compared to recently published methods, our proposed system achieved better classification results in terms of recall, and similar and higher results in terms of precision and accuracy. The proposed system also achieved an excellent receiver operating characteristic area under the curve (ROC AUC) values varying from 0.85 to 0.89. Conclusions: This research presented an effective new approach to classify different cancer types based on DNA methylation data retrieved from TCGA. The performance of the proposed system was compared to recently published works, using different performance metrics. It provided better results, confirming the effectiveness of the proposed method for classifying different cancer types based on DNA methylation data.

Classification Based on Feature Extraction for Hepatocellular Carcinoma Diagnosis Using High-throughput Dna Methylation Sequencing Data

Construction and Validation of Novel Diagnostic and Prognostic DNA Methylation Signatures for Hepatocellular Carcinoma

A new parsimonious method for classifying Cancer Tissue-of-Origin Based on DNA Methylation 450K data

Predicting Overall Survival of Patients with Hepatocellular Carcinoma Using a Three‐category Method Based on DNA Methylation and Machine Learning

Diagnostic classification based on DNA methylation profiles using sequential machine learning approaches.

Global Analysis of DNA Methylation in Hepatocellular Carcinoma Via a Whole-Genome Bisulfite Sequencing Approach

Genome-wide Plasma Cell-Free DNA Methylation Profiling to Identify High-Performing Biomarkers for Early Detection of Hepatocellular Carcinoma.

Revealing distinct DNA methylation patterns in hepatic carcinoma through high-throughput sequencing

DNA methylation fingerprint of hepatocellular carcinoma from tissue and liquid biopsies

Construction of DNA methylation-based biomarkers for diagnosis of hepatocellular carcinoma.

An aberrant DNA methylation signature for predicting hepatocellular carcinoma

Identification and Analysis of DNA Methylation-Driven Signatures for Prognostic and Immune Microenvironments Evaluation in Hepatocellular Carcinoma

A hybrid metaheuristic-deep learning technique for the pan-classification of cancer based on DNA methylation

DNA methylation-driven genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma

A Self-attention Graph Convolutional Network for Precision Multi-tumor Early Diagnostics with DNA Methylation Data

Transform-Domain Classification of Human Cells based on DNA Methylation Datasets

A New Approach to Evaluating Aberrant DNA Methylation Profiles in Hepatocellular Carcinoma as Potential Biomarkers

Tumor detection by analysis of both symmetric- and hemi-methylation of plasma cell-free DNA

A Computational Framework To Simultaneously Quantify Dna Methylation, Somatic Copy Number Alternation And Dna Heterogeneity From Low Coverage Plasma Circulating Dna Sequencing

Genome-scale detection of hypermethylated CpG islands in circulating cell-free DNA of hepatocellular carcinoma patients

Screening Dys-Methylation Genes and Rules for Cancer Diagnosis by Using the Pan-Cancer Study